Mercè Boada, leader of the MOPEAD project, shares her experiences of COVID-19 lockdown
During the lockdown, I am distancing myself socially whilst continuing my work for Fundació ACE.
During the lockdown, I am distancing myself socially whilst continuing my work for Fundació ACE.
On 10 December, two Innovative Medicines Initiative projects participated in an Alzheimer Europe Lunch Debate.
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
On 23 October (The Hague, Netherlands), Neuronet (Efficiently Networking European Neurodegeneration Research) convened the second
On 1 to 2 October, the MOPEAD closing meeting took place in Cologne. The main
Cambridge Cognition presented an interim analysis of the MOPEAD Projects patient engagement model at the Alzheimer’s Association International Conference.
Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.